BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3567301)

  • 1. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized tumor rates for chronic bioassays.
    Kodell RL; Gaylor DW; Chen JJ
    Biometrics; 1986 Dec; 42(4):867-73. PubMed ID: 3814727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating tumor incidence rates in animal carcinogenicity experiments.
    Dinse GE
    Biometrics; 1988 Jun; 44(2):405-15. PubMed ID: 3390506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Gart JJ; Tarone RE
    Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive and false-negative rates for carcinogenicity screens.
    Fears TR; Tarone RE; Chu KC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1941-5. PubMed ID: 861930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Bailer AJ
    J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analysis of disease prevalence data from survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1978 Dec; 34(4):555-70. PubMed ID: 749944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical design of toxicity assays: role of genetic structure of test animal population.
    Haseman JK; Hoel DG
    J Toxicol Environ Health; 1979 Jan; 5(1):89-101. PubMed ID: 423309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian approach to the multiplicity problem for significance testing with binomial data.
    Meng CY; Dempster AP
    Biometrics; 1987 Jun; 43(2):301-11. PubMed ID: 3607202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Hedges JC; Hoel DG
    Cancer Res; 1986 Sep; 46(9):4372-8. PubMed ID: 3731095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible carcinogenic properties of a new chromogen, dicarboxydine (gamma,gamma'-3,3'-benzidine dioxydibutyric acid), tested in rats and mice.
    Pliss GB; Volfson NI
    J Natl Cancer Inst; 1979 Feb; 62(2):301-4. PubMed ID: 283265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.